LI WILLIAM 4
4 · LEAP THERAPEUTICS, INC. · Filed Apr 4, 2023
Insider Transaction Report
Form 4
LI WILLIAM
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-03-31+150,000→ 150,000 totalExercise: $0.34Exp: 2033-03-31→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested.